1. Klevens RM, Edwards JR, Richards CL Jr. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep . 2007;122:160-166.
2. Burke JP. Infection control—a problem for patient safety. N Engl J Med . 2003;348:651-656.
3. Scott RD. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. Division of Healthcare Quality Promotion; National Center for Preparedness Detection and Control of Infectious Diseases; Coordinating Center for Infectious Diseases; Centers for Disease Control and Prevention. March 2009. Contract No.: CS200891-A. www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf .
4. Eriksen HM, Iverson BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect . 2005;60:40-45.
5. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis . 2010;50:625-663.
6. Mattie AS, Webster BL. Centers for Medicare and Medicaid Services’ “never events”: an analysis and recommendations to hospitals. Health Care Manag . 2008;27:338-349.
7. Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents . 2001;17:299-303.
8. Weinstein JW, Mazon D, Pantelick E, et al. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol . 1999;20:543-548.
9. Fakih MG, Pena ME, Shemes S, et al. Effect of establishing guidelines on appropriate urinary catheter placement. Acad Emerg Med. 2010;17:337-340.
10. Gould CV, Umscheid CA, Agarwal RK, et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol . 2010;31:319-326.
11. Fakih MG, Rey JE, Pena ME, et al. Sustained reductions in urinary catheter use over 5 years: bedside nurses view themselves responsible for evaluation of catheter necessity. Am J Infect Control . 2013;41:236-239.
12. Meddings J, Rogers MA, Krein SL, et al. Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infections: an integrative review. BMJ Qual Saf . 2014;23:277-289.
13. Gould C. Catheter-associated urinary tract infection: the national perspective. In: Essential Hospitals Engagement Network. Patient Harm Series II: new tools to prevent CAUTI webinar. April 16, 2014. http://bit.ly/1UWndRA .
14. Nicolle LE. Consequences of asymptomatic bacteriuria in the elderly. Int J Antimicrob Agents . 1994;4:107-111.
15. Nicolle LE. Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol . 2001;22:167-175
16. Cohen A. A microbiological comparison of a povidone-iodine lubricating gel and a control as catheter lubricants. J Hosp Infect . 1985;6(Suppl A):155-161.
17. Daifuku R, Stamm WE. Bacterial adherence to bladder uroepithelial cells in catheter-associated urinary tract infection. N Engl J Med . 1986;314:1208-1213.
18. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc . 1999;74:131-136.
19. Nicolle LE. Catheter-related urinary tract infection. Drugs Aging . 2005;22:627-639.
20. Redder JD, Leth RA, Møller JK. Incidence rates of hospital-acquired urinary tract and bloodstream infections generated by automated compilation of electronically available healthcare data. J Hosp Infect . 2015;91:231-236.
21. Ortega M, Marco F, Soriano A, et al. Epidemiology and prognostic determinants of bacteraemic catheter-acquired urinary tract infection in a single institution from 1991 to 2010. J Infect . 2013;67:282-287.
22. Tambyah PA, Maki DG. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med . 2000;160:673-677.
23. Musher DM, Thorsteinsson SB, Airola VM, II. Quantitative urinalysis:diagnosing urinary tract infection in men. JAMA . 1976;236:2069-2072.
24. Hausegger KA, Portugaller HR. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications. Eur Radiol . 2006;16:2016-2030.
25. Lange D, Bidnur S, Hoag N, et al. Ureteral stent-associated complications--where we are and where we are going. Nat Rev Urol . 2015;12:17-25.
26. el-Faqih SR, Shamsuddin AB, Chakrabarti A, et al. Polyurethane internal ureteral stents in treatment of stone patients: morbidity related to indwelling times. J Urol . 1991;146:1487-1491.
27. Adamo R, Saad WE, Brown DB. Management of nephrostomy drains and ureteral stents. Tech Vasc Interv Radiol . 2009;12:193-204.
28. Joshi HB, Newns N, Stainthorpe A, et al. Ureteral Stent Symptom Questionnaire: development and validation of a multidimensional quality of life measure. J Urol . 2003;169:1060-1064.
29. Singh I, Gupta NP, Hemal AK, et al. Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors. Urology . 2001;58:526-531.
30. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am . 2003;17:411-432.
31. Mobley HL, Warren JW. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol . 1987;25:2216-2217.
32. Kehinde EO, Rotimi VO, Al-Hunayan A, et al. Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol . 2004;18:891-896.
33. Paick SH, Park HK, Oh SJ, Kim HH. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent. Urology . 2003;62:214-217.
34. Klis R, Korczak-Kozakiewicz E, Denys A, et al. Relationship between urinary tract infection and self-retaining double-J catheter colonization. J Endourol . 2009;23:1015-1019.
35. Farsi HM, Mosli HA, Al-Zemaity M, et al. Bacteriuria and colonization of double-pigtail ureteral stents: long-term experience with 237 patients. J Endourol . 1995;9:469-472.
36. Wolfe JS Jr, Bennet CJ, Dmochowski RR, et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol . 2008;179:1379-1390.
37. Bahu R, Chaftari AM, Hachem RY, et al. Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. J Urol . 2013;189:130-135.
38. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) . 2013;14:73-156.
39. Cronan JJ, Horn DL, Marcello A, et al: Antibiotics and nephrostomy tube care: preliminary observations. Part II. Bacteremia. Radiology. 1989;172(3 Pt 2):1043-1045.
40. Akay AF, Aflay U, Gedik A, et al. Risk factors for lower urinary tract infection and bacterial stent colonization in patients with a double J ureteral stent. Int Urol Nephrol . 2007;39:95-98.
41. Meddings J, Saint S, Fowler KE, et al. The Ann Arbor criteria for appropriate urinary catheter use in hospitalized medical patients: results obtained by using the RAND/ UCLA appropriateness method. Ann Intern Med . 2015;162(9 Suppl):S1-34.
42. Stickler D, Young R, Jones G, et al. Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? Urol Res . 2003;31:306-311.
43. Denstedt J, Wollin T, Reid G. Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation. J Endourol . 1998;12:493-500.
44. Morris N, Stickler D, Winters C. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br J Urol . 1997;80:58-63.
45. Cardenas D, Moore K, Dannels-McClure A, et al. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. PMR . 2011;3:408-417.
46. Spinu A, Onose G, Daia C, et al. Intermittent catheterization in the management of post spinal cord injury (SCI) neurogenic bladder using new hydrophilic, with lubrication in close circuit devices-our own preliminary results. J Med Life . 2012;5:21-28.
47. Shekelle P, Morton S, Clark K, et al. Systematic review of risk factors for urinary tract infection in adults with spinal cord dysfunction. J Spinal Cord Med . 1998;22:258-272.
48. Siddiq D, Darouiche R. New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol . 2012;9:305-314.
49. Gould C, Umscheid C, Agarwal R, et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol . 2010;31:319-326.
50. Maki D, Tambyah P. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis . 2001;7:342-347.
51. Munasinghe R, Yazdani H, Siddique M, et al. Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service. Infect Control Hosp Epidemiol . 2001;22:647-649.
52. Nicolle L, Bradley S, Colgan R, et al; Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis . 2005;40: 643-654.
53. Linsenmeyer T, Oakley A. Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J Spinal Cord Med . 2002;26:352-357.
54. Abbo LM, Hooton TM. Antimicrobial stewardship and urinary tract infections. Antibiotics . 2014;3:174-192.
55. Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am . 2014;28:61-74.
56. Alvarez-Lerma F, Nolla-Salas J, Leon C, et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med . 2003;29:1069-1076.
57. Colodner R, Nuri Y, Chazan B, et al. Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. Eur J Clin Microbiol Infect Dis . 2008;27:301-305.
58. Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis . 2000;30:14-18.
59. Sobel JD, Fisher JF, Kauffman CA, et al. Candida urinary tract infections—epidemiology. Clin Infect Dis . 2011;52(suppl 6): S433-436.
60. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol . 2000;21:510-515.
61. Fisher JF, Sobel JD, Kauffman CA, et al. Candida urinary tract infections—treatment. Clin Infect Dis . 2011;52(suppl 6):S457-466.
62. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis . 2001;33:177-186.
63. Puzniak LP, Teutsch S, Powderly W, et al. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol . 2004;25:628-633.
64. Siddique MS, Gayed N, McGuire N, et al. Salient features of Candida pyelonephritis in adults. Infect Dis Clin Pract . 1992;1:239-245
65. Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis . 2016;62:e1-e50.
66. Sobel JD, Bradshaw SK, Lipka CJ, et al. Caspofungin in the treatment of symptomatic candiduria. Clin Infect Dis . 2007;44:e46-9.
67. Malani AN. Failure of caspofungin for treatment of Candida glabrata candiduria. Case report and review of the literature. Infect Dis Clin Pract . 2010;18:271-272.
68. Schelenz S, Ross CN. Limitations of caspofugin in the treatment of obstructive pyelonephrosis due to Candida glabrata infection. BMC Infect Dis . 2006;56:126-130.
69. Chung BH, Chang SY, Kim SI, et al. Successfully treated renal fungal ball with continuous irrigation of fluconazole. J Urol . 2001;166:1835-1836.
